GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (NYSE:ABT) » Definitions » Cyclically Adjusted Price-to-FCF

ABT (Abbott Laboratories) Cyclically Adjusted Price-to-FCF : 37.76 (As of Jun. 27, 2025)


View and export this data going back to 1949. Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2025-06-27), Abbott Laboratories's current share price is $133.67. Abbott Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $3.54. Abbott Laboratories's Cyclically Adjusted Price-to-FCF for today is 37.76.

The historical rank and industry rank for Abbott Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ABT' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 11.08   Med: 30.41   Max: 48.66
Current: 38.87

During the past years, Abbott Laboratories's highest Cyclically Adjusted Price-to-FCF was 48.66. The lowest was 11.08. And the median was 30.41.

ABT's Cyclically Adjusted Price-to-FCF is ranked worse than
56.05% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 35.005 vs ABT: 38.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abbott Laboratories's adjusted free cash flow per share data for the three months ended in Mar. 2025 was $0.534. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.54 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted Price-to-FCF Chart

Abbott Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.46 47.68 36.85 34.54 33.12

Abbott Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.72 31.31 33.80 33.12 37.52

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted Price-to-FCF falls into.


;
;

Abbott Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Abbott Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=133.67/3.54
=37.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Abbott Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.534/134.9266*134.9266
=0.534

Current CPI (Mar. 2025) = 134.9266.

Abbott Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.482 100.684 0.646
201509 0.521 100.392 0.700
201512 0.388 99.792 0.525
201603 -0.226 100.470 -0.304
201606 0.447 101.688 0.593
201609 0.613 101.861 0.812
201612 0.573 101.863 0.759
201703 0.174 102.862 0.228
201706 0.627 103.349 0.819
201709 0.993 104.136 1.287
201712 0.737 104.011 0.956
201803 0.472 105.290 0.605
201806 0.535 106.317 0.679
201809 1.032 106.507 1.307
201812 0.732 105.998 0.932
201903 0.212 107.251 0.267
201906 0.332 108.070 0.415
201909 0.867 108.329 1.080
201912 1.112 108.420 1.384
202003 0.199 108.902 0.247
202006 0.381 108.767 0.473
202009 0.878 109.815 1.079
202012 1.742 109.897 2.139
202103 1.250 111.754 1.509
202106 0.956 114.631 1.125
202109 1.252 115.734 1.460
202112 1.376 117.630 1.578
202203 0.983 121.301 1.093
202206 1.150 125.017 1.241
202209 1.311 125.227 1.413
202212 0.979 125.222 1.055
202303 0.436 127.348 0.462
202306 0.398 128.729 0.417
202309 0.753 129.860 0.782
202312 1.308 129.419 1.364
202403 0.358 131.776 0.367
202406 0.815 132.554 0.830
202409 1.230 133.029 1.248
202412 1.232 133.157 1.248
202503 0.534 134.927 0.534

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott Laboratories  (NYSE:ABT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Abbott Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Executives
Sally E. Blount director 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064-6400
Lisa D Earnhardt officer: Executive Vice President 1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025
Andrea F Wainer officer: Executive Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Mary K Moreland officer: Executive Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Louis H. Morrone officer: EXECUTIVE VICE PRESIDENT 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Mccoy John A. Jr. officer: VICE PRESIDENT C/O ABBOTT LABORATORIES, 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Robert B Ford officer: Senior Vice President 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Salvadori Daniel Gesua Sive officer: Senior Vice President 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Hubert L Allen officer: Executive Vice President 100 ABBOTT PARK ROAD, AP6C-1N, ABBOTT PARK IL 60064-6092
Robert E Funck officer: Vice President, Controller 100 ABBOTT PARK ROAD, D-378, AP6D-2, ABBOTT PARK IL 60064-6092
Daniel J Starks director ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Michael F Roman director 3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST. PAUL MN 55144-1000
Patricia Paola Gonzalez director 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Philip P Boudreau officer: Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Michael O'grady director 50 S LASALLE STREET, CHICAGO IL 60603